Dr. Katharina Schlereth

Vascular Biology, Medical Faculty Mannheim, Heidelberg University

Vascular Oncology and Metastasis,

German Cancer Research Center, Heidelberg


Katharina Schlereth received her PhD at the Philipps-University in Marburg under the supervision of Thorsten Stiewe, where she also pursued postdoctoral training before she moved to the Division of Vascular Oncology and Metastasis at the DKFZ for a senior postdoctoral position.

Qualifications and Scientific Curriculum




since 2013

Diploma: Biology, Julius-Maximilians-University Würzburg, Germany

PhD: Molecular Oncology, Philipps-University, Marburg, Germany

Postdoctoral research fellow, Division of Molecular Oncology, Philipps-University Marburg, Germany

Postdoctoral research fellow, Division of Vascular Oncology and Metastasis, DKFZ, Heidelberg and Department of Vascular Biology, Medical Faculty Mannheim, Heidelberg University, Germany

Ich bin ein Textabschnitt. Klicken Sie hier, um Ihren eigenen Text hinzuzufügen und mich zu bearbeiten.

Selected publications

  1. Schlereth K, Weichenhan D, Bauer T, Heumann T, Giannakouri E, Lipka D, Jaeger S, Schlesner M, Aloy P, Eils R, Plass C, Augustin HG: The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. Elife, 7:pii:e34423, 2018.

  2. Teichert M, Milde L, Holm A, Stanicek L, Gengenbacher N, Savant S, Ruckdeschel T, Hasanov Z, Srivastava K, Hu J, Hertel S, Bartol A, Schlereth K**, Augustin HG**: Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nat commun, 8:16106, 2017 (**joint last authors).

  3. Schlereth K, Heyl C, Krampitz AM, Mernberger M, Finkernagel F, Scharfe M, Jarek M, Leich E, Rosenwald A, Stiewe T: Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Genet, 9:e1003726, 2013.

  4. Timofeev O, Schlereth K, Wanzel M, Braun A, Nieswandt B, Pagenstecher A, Rosenwald A, Elsässer HP, Stiewe T: p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo. Cell Rep, 3:1512-25, 2013.

  5. Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H, Biton S, Snir-Alkalay I, Vucic D, Schlereth K, Mernberger M, Stiewe T, Oren M, Alitalo K, Pikarsky E, Ben-Neriah Y: A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell, 24:242-56, 2013.

  6. Schlereth K, Charles JP, Bretz AC, Stiewe T: Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle, 9:4068-76, 2010.

  7. Schlereth K*, Beinoraviciute-Kellner R*, Zeitlinger MK, Bretz AC, Sauer M, Charles JP, Vogiatzi F, Leich E, Samans B, Eilers M, Kisker C, Rosenwald A, Stiewe T: DNA binding cooperativity of p53 modulates the decision between cell cycle arrest and apoptosis. Mol Cell, 38:356-68, 2010 (*equal contribution).

  8. Griesmann H*, Schlereth K*, Krause M, Samans B, Stiewe T: Role of p53 and p73 in suppression of Myc-driven lymphomagenesis. Int J Cancer, 124:502-6, 2009 (*equal contribution).


European Center for Angioscience

Medical Faculty Mannheim
Heidelberg University

Ludolf-Krehl-Straße 13-17
D-68167 Mannheim

Phone +49 621/383-71450